Shortlist Revealed for the Second Annual BioPharmaChem Impact Awards
BioPharmaChem Ireland (BPCI), IDA Ireland, and Enterprise Ireland have announced the shortlist for its annual awards recognising and celebrating the outstanding achievements and potential within the BioPharmaChem sector in Ireland. The sector is a key pillar of the Irish economy, employing more than 65,000 people directly, with a further 30,000 jobs supported indirectly.
The shortlisted companies have demonstrated excellence across numerous categories, including innovation, digitalisation, sustainability, collaboration, and talent strategy, with entries reviewed by an esteemed panel of independent judges, comprised of senior leaders from across Irish business.
The winners will be announced at the BioPharmaChem Impact Conference and Awards Dinner taking place at the InterContinental Hotel, Dublin 4, on the 6th May. This prestigious event will bring together over 450 industry leaders, innovators, and stakeholders to celebrate the remarkable contributions and advancements within the BioPharmaChem sector.
Speaking ahead of the announcement, Dr Sinead Keogh, Head of Sectors at Ibec and Director of BioPharmaChem Ireland, said: “The BioPharmaChem sector in Ireland continues to go from strength to strength, and has firmly established itself as a key economic driver. The strength and performance of the industry is evident in the quality of submissions across all our Award categories. We are looking forward to coming together to celebrate some genuinely world-class work taking place in Ireland, which is setting a high standard globally for excellence and innovation.
The shortlisted companies are:
- BioPharmaChem Company of the Year Award 2026: APC and VLE Therapeutics, MSD Ireland, Takeda Ireland
- Sustainable BioPharmaChem Company of the Year Award 2026: Alexion-AstraZeneca Rare Disease, Sanofi, WuXi Biologics
- Collaboration in BioPharmaChem Award 2026: Arran Chemical Company, Brightbeam AI Ltd, Pharmaceutical Manufacturing Technology Centre
- Best Process Innovation/Digitalisation of the Year Award 2026: Astellas Pharma Ltd, Pfizer Ireland Pharmaceuticals, Sanofi
- Emerging BioPharmaChem Company of the Year Award 2026: ArrayPatch Ltd, Dunbar Pharma, Phanero
- BioPharmaChem Partner/Supplier of the Year Award 2026: DHL Health Logistics, Ireland, NIBRT, Thermo Fisher Scientific
- Best Talent Strategy of the Year Award 2026: Johnson & Johnson Innovative Medicine, MSD Ireland, WuXi Biologics
Cepta Duffy, Head of Lifescience and Healthtech at Enterprise Ireland remarked: “The BioPharmaChem Impact Awards 2026 highlight the strength and ambition of Irish-owned companies across this vital sector. The shortlisted organisations showcase the innovation, collaboration and global focus that is driving Ireland’s lifesciences ecosystem forward. Enterprise Ireland will continue to help Irish companies to compete across the global biopharma value chain, to support their international scaling agenda.”
Rory Mullen, Head of BioPharma & Food, IDA Ireland said: “IDA Ireland is proud to support the BioPharmaChem Impact Awards, which demonstrate the continued growth and global leadership of Ireland’s biopharma and chemical sectors. The companies shortlisted demonstrate the advanced capabilities, innovation and talent that underpin Ireland’s position as a premier location for high-value manufacturing and investment. We remain committed to supporting the sector’s evolution, particularly in areas such as digitalisation, sustainability and next-generation biopharma.”
BPCI extends its sincere thanks to the 2026 Impact Awards sponsors, including Platinum sponsors Chemco Ireland, Frontier Scientific Solutions, and WuXi Biologics; Gold sponsors BioPharmaChem Skillnet, Brightbeam, Camida, DHL, EY, Indaver, PMTC, and SkyCell; and Silver sponsors Innopharma Education, LSC, Life Science Recruitment, Ibec Laboratory Apprenticeship, Micro Bio, and National Chemical Company.
